Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus that establishes a lifelong carrier state in the infected host. Asymptomatic carriage of this lymphotropic tumor virus is achieved by a virus-host equilibrium that holds in check the otherwise proliferative properties provoked by virus in infected cells. The immunodominant latency proteins of EBV that support its cell growth-transforming ability are largely downregulated in infected cells of the carrier state to avoid immune surveillance, thereby placing the vast majority of infected individuals beyond risk for EBV-induced cancer. Should this steady state be disrupted by host immune impairment and reexpression of EBV's full growth program, malignant manifestations such as post-transplant lymphoproliferative disease and EBV-linked AIDS-associated malignancies can emerge (68) .
The pathogenesis of EBV-linked cancers in the immunecompetent host is less clear-cut, although a dramatic antibody response to EBV lytic proteins in the years preceding clinical onset suggests the possibility of a novel reactivation event underlying the ensuing adverse outcome (34, 42, 43, 60, 79) . In terms of the virus-host equilibrium, the balance under these circumstances seems disrupted by virus, the outcome being determined less by host-defined conditions than by enhanced viral potency. Although EBV type and strain differences have been extensively studied, efforts to link EBV variants to specific disease entities have not provided satisfactory evidence of causality to date (52) .
Early EBV genomic mapping studies, however, provided a hint of what may be a contributing factor to viral pathogenesis during the lifelong carrier state: recombination and rearrangement of endogenous virus, with resulting mutants exhibiting a remarkable variation of biological activity to include functional complementation of the standard coexisting EBV genome. First, an Epstein-Barr nuclear antigen 2 (EBNA2) deletion mutant termed P3HR-1, incapable of immortalizing B lymphocytes, was isolated in a cell clone of the Burkitt lymphoma (BL) cell line Jijoye, which originally contained standard transforming virus (2, 17, 29, 40, 47, 54) . Considered a likely consequence of propagation in cell culture (48) , deletions similar to that of P3HR-1 were subsequently reported in virus found in other BL cell lines (23, 30) , clinical throat washings (62) , and oral hairy leukoplakia lesions (71) . Although nontransforming in vitro, the potential of these viral variants to alter the course of natural infection has only recently become evident. The derivation of EBNA2 deletion mutants from coresident standard genomes has now been reported in a subset of endemic BL, where only the EBNA2-deleted genome is active transcriptionally, its less restricted pattern of gene expression providing BL cells with a decided survival advantage (25) (26) (27) .
Also observed in initial studies of P3HR-1-containing BL clones was the existence of two populations of EBV molecules, one representative of the more complete standard genome and the other consisting of submolar, heterogeneous (het), rearranged EBV DNA fragments (1, 9, 12, 16, 49, 55) . Although the finding was not limited solely to the P3HR-1 cell line (16) , the best characterization of het DNA, both molecularly and biologically, has been achieved with P3HR-1-infected cells (6, 7, 18, 19, 21, 38, 39, 53) . As yet to be implicated in the actual pathogenesis of human disease, het DNA has been detected even in the absence of the standard EBV genome in a variety of pathogenic states (oral hairy leukoplakia [47] , thymic carcinoma [46] , Burkitt's lymphoma [51] , Hodgkin's lymphoma [13] , idiopathic pulmonary fibrosis [24] , and AIDS saliva [18] ). Given the unusual capacity of het DNA to disrupt the latency of standard EBV in vitro (14, 39) , there exists at least the potential for its alteration of outcomes, either acutely in the establishment phase of infection or in the lifelong carrier state as diseases of reactivation. Here, we describe the isolation of het DNA in long-term epithelial cell culture in the absence of standard EBV. As a natural cloning event, integration into host cell DNA gives added credence to earlier clinical reports of such an occurrence and provides a singular opportunity to define further the biological potential of het DNA without the confounding influence of a coresident standard EBV genome.
MATERIALS AND METHODS
Cell lines and virus preparations. P3HR-1 clones 5 and 13 (gift of G. Miller, Yale University) are Burkitt lymphoma (BL)-derived B-cell lines (48, 49) , both of which contain the nontransforming EBNA2-deleted variant of EBV (40, 54) . Clone 5 is also positive for subgenomic rearranged het DNA in approximately 1/200 cells (39) . Subclone 5/3 is a het DNA-negative derivative of clone 5 containing only the standard P3HR-1 genome. BL2 and Namalwa are EBVnegative and EBV-positive BL cell lines, respectively. B95-8 is an EBV-positive marmoset-derived lymphoblastoid B-cell line. P3HR-1 clone 5 cells were maintained in RPMI 1640 medium (CellGro) supplemented with 100 g/ml penicillinstreptomycin and 7% fetal bovine serum (FBS) and incubated at 34°C in 5% CO 2 . Other lymphoid cell lines were similarly maintained but in 10% FBS at 37°C. SVKCR2-CIITA (gift of L. Hutt-Fletcher, LSU Health Sciences CenterShreveport) is a keratinocyte cell line stably transfected with plasmids expressing the EBV receptor CR2 and the human class II transactivator CIITA (4, 35) . CCL20.2CR2-CIITA is a carcinoma cell line of mucosal origin stably transfected with CR2 and CIITA (CCL.20.2, American Type Culture Collection). Transfected epithelial cells were grown in Joklik's modified Eagle's medium supplemented with 10% bovine calf serum, 10 ng of cholera toxin (Sigma)/ml, 400 g of G418 (Mediatech)/ml, and 0.2 g of puromycin (Sigma)/ml. P3HR-1 virus stocks derived from clone 5, subclone 5/3, and clone 13 were prepared by treatment of cells with 20 ng of tetradecanoylphorbol-13-acetate (TPA; Sigma)/ ml. Culture supernatants were then concentrated 20ϫ using a Labscale tangential flow filtration (TFF) system (Millipore) and stored at Ϫ80°C. To determine EBV genome equivalents/ml of virus stock, virion preparations were treated with DNase to remove any nonencapsidated EBV DNA. Virion DNA was then extracted for quantification on slot blot, using Namalwa total cellular DNA (2 EBV copies per cell) as the standard. For infection, CCL20.2-and SVKCR2-CIITA cells were incubated for 5 h with ϳ40 EBV genome equivalents/cell and then washed with medium. SVKCR2-CIITA cell clones (SVK5 4G2 and SVK5 4H3) were derived from infected bulk culture by single-cell sorting (FACSVantage SE; Becton Dickinson).
DNA PCR and RT-PCR. DNA PCR was performed for 35 cycles (94°C for 30 s; 55°C for 1 min; 72°C for 1 min) in a 50-l reaction mixture containing 100 ng of total cellular DNA, 0.6 M primers, 0.2 M deoxynucleoside triphosphates (dNTPs) (Promega), and 0.5 U Taq DNA polymerase in the manufacturer's buffer (Promega) on a PTC-200 thermal cycler (MJ Research). PCR products were electrophoresed on a 2% SeaKem LE agarose gel with 1ϫ Tris-acetate-EDTA buffer (TAE). Gels were denatured with 0.5 M NaOH-1.5 M NaCl and then neutralized with 0.5 M Tris-HCl (pH 7)-1.5 M NaCl. DNA was transferred by Southern blotting to nylon membranes (GE Osmonics), cross-linked by UV (Bio-Rad Laboratories), and hybridized with oligonucleotide probes end labeled with a [␥- 32 P]ATP by T4 polynucleotide kinase (USB). Oligonucleotide primers and probes for three points of recombination in het DNA monomers (GenBank accession numbers M20820, EU669823, EU669824), BKRF1, and BERF2b were previously described (18, 22, 56) . Additional primer sequences are BMRF1 (forward 5Ј-CAGGCTGAGGAACGAGCAC-3Ј [coordinates 63072 to 68090; AJ507799] and reverse 5Ј-CAACGAGGAAGCCGTCTTG-3Ј [68135 to 68117, AJ507799]) and BDLF2 (forward 5Ј-GCCTCTCCATCGTCGACATCT TCC-3Ј [119578 to 119601; AJ507799] and reverse 5Ј-GTCGATGAACAAGT GGCGG-3Ј [120098 to 120080, AJ507799]). As a control, the following primers to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) DNA were used to ensure equal DNA loading: forward primer 5Ј-GATGGGCAGCCCCTTCAT A-3Ј and reverse primer 5Ј-GGGTGGAATCATATTGGAACATG-3Ј. For reverse transcription-PCR (RT-PCR) of BALF4-encoded gp110 (gB), RNA was extracted according to the RNA STAT60 protocol (Tel-test) from het DNAinfected SVKCR2-CIITA cell clones that either were untreated or had been treated with the histone deacetylase inhibitors trichostatin A (TSA; 300 nM) or sodium butyrate (NaB; 3 mM); DNA methyltransferase inhibitors 5-aza-2Ј-de-
or the phorbol ester of TPA (20 ng/ml). For cDNA synthesis, 1 g of RNA was reversed transcribed with Moloney murine leukemia virus reverse transcriptase (Invitrogen) by using random hexamer primers. The BALF4 primers and probe for cDNA amplification were as follows: forward primer 5Ј-AACCTTTGACTCGACCATCG-3Ј (157962 to 157943; AJ507799), reverse primer 5Ј-CATGCATGGTCTTGTTCACC-3Ј (157808 to 157827; AJ507799), and probe 5Ј-GTCACGAAGCTAGAGGTGCC-3Ј (157882 to 157901; AJ507799). The amplification of GAPDH transcripts was used as a loading control with the following primers: forward primer 5Ј-GAAGGTGAA GGTCGGAGT-3Ј and reverse primer 5Ј-GAAGATGGTGATGGGATTTC-3Ј. EBNA1 transcript levels were quantified using the TaqMan-based real-time PCR assay previously described (70) and normalized to GAPDH (Applied Biosystems). EBNA1 promoter usage (Fp, Qp, Cp/Wp) was determined using previously described primer sets (69, 80) . The BZLF1 cDNA amplification was quantified using the following primers and probe: forward primer 5Ј-TTAT TTCTAGTTCAGAATCGCATTCC-3Ј (90212 to 90237; AJ507799), reverse primer 5Ј-CCGGCACGACGCACA-3Ј (90405 to 90391; AJ507799), and probe 5Ј-CAGCGATTCTGGCTGTTGTGG-3Ј (90367 to 90387; AJ507799).
Definition of het DNA concatemeric linkage and sequencing of PCR products. Guided by previous restriction maps of het DNA (6), 4 pairs of PCR primers were empirically selected to span a putative junction connecting het DNA monomers. Based on sequence data from the complete wild-type EBV genome (GenBank accession number AJ507799), the initial leftmost primer targeted the BamHI A fragment, with subsequent leftmost primers shifted to the right of the BamHI A/Nhet restriction site (coordinate 166156) progressively closer to terminal repeat (TR) sequences; the rightmost primer of each set targeted sequences within the TRs. The 5Ј coordinates of the 4 initial primer sets were as follows: 166048 and 170065; 166311 and 170065; 166630 and 170065; and 166630 and 170104. Once localized, the junction was amplified with the following primer set: 5Ј-TTGGATGCAGTCCTCCGCAT-3Ј (166630) and 5Ј-TCACGTTTGCC GGGGTCAG-3Ј (170065). DNA PCRs contained 0.2 M dNTPs, 1ϫ Green GoTaq buffer, 1ϫ combinatorial enhancer solution (1.3% dimethyl sulfoxide [DMSO], 11 g/ml bovine serum albumin [BSA]) (50), 0.2 M (each) forward and reverse primer, 0.5 units GoTaq DNA polymerase, and 100 ng (0.5 l) template DNA. DNA amplifications were initiated at 95°C for 5 min and then cycled 35 times (95°C for 30 s, 60°C for 45 s, 72°C for 1 min) followed by 72°C for 5 min. PCR products electrophoresed on a 1.5% agarose gel with 1ϫ TAE were cut from gels and purified with a QIAquick gel extraction kit (Qiagen), and sequences were determined by fluorescent dye terminator sequencing (SeqWright DNA Technology). The point of recombination was determined by sequence alignment with data from wild-type EBV and P3HR-1 genomes (GenBank accession numbers AJ507799 and EF164992, respectively).
Nucleoporation. EBV gB cloned into the pCAGGS/MCS vector for expression under the control of the ␤-actin promoter and the human cytomegalovirus immediate-early enhancer was the gift of L. Hutt-Fletcher (76) . Two micrograms of gB expression vector was introduced into 2 ϫ 10 5 SVKCR2-CIITA cells by using an Amaxa nucleofector device in conjunction with Cell Line Nucleofector Kit T as per the manufacturer's program P-29 (Amaxa).
Indirect immunofluorescence and immunoblotting for EBV proteins. Monoclonal antibody (MAb) BZ1 (77), specific for the BZLF1-encoded gene product (Zta, EB1, Zebra), was the gift of L. S. Young (University of Birmingham). MAb specific for EBV gB (gp110), designated CL55 (gift of L. Hutt-Fletcher) (76) (41). FISH. The Akata-based bacterial artificial chromosome (Akata-BAC; gift of L. Hutt-Fletcher) was used as the probe after labeling by nick translation with digoxigenin-11-dUTP (Boehringer-Mannheim). The probe was hybridized to fixed interphase or metaphase chromosomes as previously described (58) and detected by fluorescein-conjugated sheep antibodies to digoxigenin (BoehringerMannheim).
Southern blotting. Thirty micrograms of DNA from SVK5 4G2, SVK5 4H3, and Namalwa was digested overnight with BamHI. Samples were electrophoresed on a 0.8% agarose in 1ϫ Tris-borate-EDTA buffer at 50 V for 18 h. Electrophoresed DNA was transferred onto a nylon membrane using a standard protocol (63) . Membranes were probed with a random-primed Akata BAC as a probe. Membranes were stripped and reprobed with random-primed EBV BamHI fragments to verify the identity of each band.
Nucleotide sequence accession number. The sequence data defining the point of recombination between EBV het DNA monomers comprising the concatemeric configuration have been assigned the GenBank accession number HQ263413.
RESULTS
EBV het DNA entry into epithelial cell model system. Because laboratory strains of EBV manifest variable efficiencies of infection in epithelial cells (36), we first optimized the attachment and entry of P3HR-1-derived virus by using cells stably transfected with CR2, the B-lymphocyte EBV attachment receptor (11) , and CIITA, inducer of the B-cell EBV coreceptor, HLA class II (35) . Both molecules were required for the efficient infection of epithelial targets with P3HR-1 virus (Fig. 1A) , presumably a consequence of the HLA class II alleles expressed by P3HR-1 cells themselves. EBV propagated in B lymphocytes characteristically bears an envelope with an enhanced ratio of two-part EBV glycoprotein complex gH/gL (favorable to epithelial cell infection) to the tripartite complex gH/gL/gp42 (required for B-cell entry) (3). The relative proportions of the two complexes vary with the HLA class II status of the virus-producing cell itself, with intracellular sequestration and degradation of gp42 occurring if gp42 is bound by HLA class II alleles -DR and -DP during biosynthesis (3). Unlike most B lymphocytes, P3HR-1 cells express only HLA-DQ (45), which rarely binds gp42 (15, 35) . Consequently, P3HR-1-derived virions bear envelopes with increased gH/gL/ gp42 that utilize surface HLA class II as the coreceptor.
EBNA1 expression at establishment phase of infection. Expression of the EBV nuclear antigen 1 (EBNA1) is essential for the stable maintenance of the viral episome in infected cells, supporting both plasmid replication and equal apportionment to cells at mitosis. The loss of virus from infected epithelial cells during prolonged culture has been attributed to a decline in EBNA1 expression (31, 57) . The accelerated loss of episomes from latently infected lymphocytes has also been observed with forced expression of the EBV immediate-early gene BZLF1 in transient-transfection assays (66) . BZLF1-encoded Zta not only suppresses activity of the EBNA1 promoter Qp utilized in the restricted (type 1) pattern of latency gene expression (5) but also negatively regulates the Wp and Cp promoters typically active during early infection, when all latency genes (latency III) are required to contribute to the growth phenotype of infected cells (28, 61, 66) . Although het DNA lacks the EBNA1-encoding region (6), it constitutively expresses Zta from its rearranged WZhet DNA fragment (14, 53) .
To determine if EBNA1 expression from the standard genome is disproportionately suppressed when accompanied by het DNA in acutely infected epithelial cells, we infected CCL20.2CR2-CIITA cells with virus preparations containing either standard virus plus het DNA (derived from P3HR-1 cell clone 5) or standard virus only (prepared from subclone 5/3, recently isolated to minimize genomic differences). The two infectious inocula were normalized to contain 40 genome equivalents of standard P3HR-1 DNA per target cell. By quantitative RT-PCR (qRT-PCR), EBNA1 mRNA levels were markedly reduced in cells infected with het DNA-containing virus preparations at each time point measured (Fig. 1B) . The approximately 7-fold reduction in EBNA1 in het DNA-positive infections was coincident with the expected elevation of Zta mRNA, which was measured by TaqMan-based real-time RT-PCR to be 1.4-fold at 1 day postinfection (dpi), 3.5-fold at 2 dpi, 8.3-fold at 4 dpi, and 3.1-fold at 5 and 10 to 12 dpi over the levels seen for the het DNA-negative counterpart. Similar results were obtained in a second epithelial cell line, SVKCR2-CIITA, by using viral stocks derived from the established P3HR-1 het DNA-negative cell clone 13 and het DNApositive clone 5. With Zta highly expressed at day 4 in het DNA-positive SVK cell populations (hereafter referred to as SVK5) ( Fig. 2A) , EBNA1 mRNA levels were reduced in comparison to the het DNA-negative (SVK13) control ϳ3-fold (Fig. 2B) . Together, these two results implicate het DNA in the modulation of EBNA1 levels at the establishment phase of infection, although the loss of EBNA1 mRNA was evident in the het DNA-positive and -negative cell populations.
In B cells, the early transcription of latency genes is initiated from the promoter Wp, followed by Cp-initiated Y-U-K transcripts encoding EBNA1. By contrast, in epithelial cells, the predominant transcript is from the Qp-initiated Q-U-K splice associated with restricted latency I (31, 57). To determine if EBNA1 promoter usage by the standard genome was altered in the presence of het DNA, primer sets that amplify the Cp/Wp-initiated (Y3-U-K spliced) EBNA1 mRNA and the Qp-initiated (Q-U-K spliced) transcripts (Fig. 2C) were used. In the control B95-8 cells, which express latency III genes initiated at Cp/Wp, the Y3-U-K splicing pattern of EBNA1 predominated as expected. The smaller portions of transcripts detected with the Q-K primer set (Fig. 2C) (Fig. 2C) . However, SVK13 cells without het DNA contained mRNA with the U-K but not the Q-K splice, suggesting initiation upstream at Wp/Cp or the lytic promoter Fp. By contrast, het DNA-positive SVK5 cells bore the Q-U-K spliced product. A primer set specific for the Fp-initiated transcript confirmed a lack of lytic Fp activity in both SVK5 and SVK13 cells (data not shown). Hence, at early time points postinfection, coinfecting het DNA that lacked the EBNA1 open reading frame appeared to affect both the promoter usage and the levels of EBNA1 expression from the standard genome.
Loss of standard genome with het DNA retention. EBV genome loss soon after infection of epithelial cells in vitro has been well documented (10, 31, 57) . To determine if het DNA accelerated the loss of coinfecting standard EBV virus, the persistence of each in SVK5 versus SVK13 cells was monitored over the first 180 days postinfection. We targeted for PCR amplification DNA sequences in BHRF1, an open reading frame present in standard virus but not retained by het DNA (Fig. 3A) . Similarly, primers spanning the junction of aberrantly juxtaposed BamHI W and Z fragments (WZhet) were used to detect the presence of het DNA (Fig. 3A) . Although only semiquantitative, the PCR signal for BHRF1 obtained from epithelial cells infected with both viral preparations at day 1 postinfection indicated efficiencies of infection comparable with those observed for the standard EBV genome (Fig.  3B) . The persistence of the standard genome was evident for up to 100 days in both SVK13 and SVK5 cells but was no longer detected after this time point. Quite unexpectedly, het DNA persisted in SVK5 cells in the absence of standard virus (Fig. 3B) .
To facilitate additional analyses of retained EBV DNA, the SVK5 bulk cell culture was single cell cloned 206 days postinfection (passage 26). By PCR analysis, 5 of 165 cell clones screened were positive for a WZhet fragment, whereas none contained BHRF1, indicative of standard virus. Clones 4G2 and 4H3 were selected for further study. To eliminate the possibility that DNA fragments unique to standard virus were also present, we performed a genome-wide screen of het DNApositive SVK5 clones 4G2 and 4H3 by Southern blotting of total cellular DNA hybridized to a probe derived from Akata-BAC (Fig. 3C) . The control lane, containing two copies per cell of the wild-type standard EBV genome from the Namalwa BL cell line (37), had numerous bands not detected in SVK5 clones. The identification of specific het DNA fragments, indicated to the right of the blot (Fig. 3C) , was made by rehybridization of the blot with probes derived from cloned EBV DNA fragments EcoRI C and BamHI NJhet, C, Z, W, S, and M, which overlap DNA segments comprising the het DNA genome ( Fig. 3A ; also data not shown). The molecular sizes of the identified het DNA fragments were consistent with those previously reported (6, 21, 32, 49) . To ascertain whether the het DNA retained in the SVK5 cells was fully intact, PCR primers that frame the three points of recombination previously identified in P3HR-1 clone 5 virus were used (18) . In each SVK5 cell clone examined, a PCR product was obtained for all three points of recombination linking the four EBV DNA segments comprising P3HR-1-derived het DNA (Fig. 3D) . No product was generated from BHRF1, BERF2b, BKRF1, BMRF1, or BDLF2 found in the standard genome. As controls, P3HR-1 cell clone 5, containing both het DNA and standard genomes, yielded products in all eight reactions, and P3HR-1 clone 13 and Namalwa cells containing only standard EBV genome produced products only for BHRF1, BERF2b, BKRF1, BMRF1, and BDLF2. BL2 cells negative for EBV did not yield product. In sum, these results indicate the successful propagation of het DNA in long-term epithelial cell culture in isolation from the standard EBV genome.
Intact het DNA integrated and packaged in a concatemeric configuration. Although considered to be an independent replicon (38) , het DNA is presumed to require the presence of standard EBV genome for helper functions if it is to persist. Previously, its presence in human tumors in the absence of standard EBV has been reported, but the mechanism for such persistence was not addressed (13, 51) . To determine if het DNA had integrated, fluorescence in situ hybridization (FISH) analysis of interphase and metaphase chromosomes was performed using the Akata-BAC as the probe. The detection of a symmetrical doublet signal on sister chromatids in both interphase and metaphase spreads was consistent with a single integration event (Fig. 4A ). Because the rare integration of EBV DNA often involves its terminal repeat (TR) sequences, the structure of TRs in SVK5 clones was examined via Southern blotting of total cellular DNA with a TR-specific probe (Fig. 4B) . TR analysis revealed three bands, consistent with integration of the het DNA genome as a concatemer.
To further corroborate the concatemeric structure of integrated het DNA, we devised a series of primer sets guided by earlier restriction analyses of the het DNA genome (6) (Fig.  3A) . With the goal of identifying the point of recombination between successive het DNA monomer units, primers were empirically selected to frame the postulated junctional sequence. One primer of each set was specific for TR sequences, and the second moved progressively from BamHI A fragment rightward across the BamHI A/Nhet restriction site toward the TRs (Fig. 3A) . The term "het" in BamHI Nhet and Jhet fragments refers to size heterogeneity due to variance in the TR number adjacent to N and J unique sequences in the standard viral genome. Because TR sequences are GC rich, the PCR was optimized by the addition of DMSO and BSA (50) . Sequenced PCR products identified the fusion point between het DNA monomers as occurring 499 bp to the right of the BamHI A/Nhet restriction site in unique sequences of BamHI Nhet (coordinate 166655, AJ507799), there being a 5-bp overlap with the abnormally juxtaposed TR sequence from Jhet (coordinate 169637, AJ507799) (Fig. 4C) . This site is consistent with one previously suggested by restriction enzyme analysis of fusion fragments from het molecules (6) .
Reiteration of the ϳ50-kb het DNA genome in a concate- BL cell line, with the notations "cell" and "virion" indicating the source of DNA for PCR; P3HR-1 clone 13 is the het DNA-negative control. Bottom, bold underlined type indicates the junctional nucleotide sequence between concatemers, putatively linking the unique sequences in the truncated BamHI Nhet fragment of one monomer (Fig. 3A) to the BamHI Jhet of the next (the term "het" here refers to a variable number of terminal repeats adjacent to N and J unique sequences of the standard genome). Boxed residues indicate points of recombination at overlapping base pairs shared by both BamHI fragments that may be contributed by either one. Lightface type indicates residues excluded from the het DNA recombinant. Sequence coordinates joining BamHI Nhet to Jhet are 166651 to 166655 and 169637 to 169641, derived from AJ507799.
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on June 26, 2017 by guest http://jvi.asm.org/ meric structure had previously been predicted on the supposition it may be required for efficient packaging into infectious particles (6, 21) . To determine if cell-free infectious virions themselves contained het DNA concatemers, culture supernatants from P3HR-1 clone 5 were first concentrated and then treated with DNase to remove any nonencapsidated EBV DNA. PCR amplification with primers targeting sequences linking het DNA monomers yielded a product, confirming encapsidation of het DNA as concatemers (Fig. 4C) . Integrated het DNA encodes gene products with the capacity to alter EBV biology. Early studies of het DNA gene expression utilized cloned het DNA fragments derived from virion preparations (21) or P3HR-1-superinfected Raji cells (7) . Their ability to express viral polypeptides out of the context of the entire het DNA molecule was determined in transienttransfection assays with human sera from EBV-positive donors. Because defective het DNA genomes have not previously been propagated in the absence of standard virus, the natural cloning event represented here by integration of a het DNA concatemer provides a unique opportunity to analyze expression from a wholly intact het DNA genome. The single integration event detected by FISH (Fig. 4A) , its absence by PCR (Fig. 3B) , and the whole-genome screen of DNA fragments other than those comprising the het DNA molecule (Fig. 3C ) all attest to the loss of the standard genome.
To assess the usefulness of SVK5 cell clones for profiling het DNA gene expression, we used the BZ1 monoclonal antibody (77) to determine if BZLF1, which is constitutively expressed as a consequence of the WZ recombination in het DNA (53) , was present in SVK5 cell clones. The WZhet fragment is responsible for the stable conversion of latent EBV infection of lymphoid cells to a productive, lytic phase with release of progeny virus (14, 39) . The ϳ39-kDa het DNAencoded BZLF1 immediate-early protein Zta (8, 20, 67) was detected by immunoblotting in both SVK5 clones established 206 days postinfection. Indirect immunofluorescence demonstrated the characteristically nuclear location of the Zta protein (Fig. 5A) .
Because published studies using transiently transfected cloned het DNA fragments had indicated expression of a cytoplasmic polypeptide of approximately 95 kDa that mapped to the BamHI A fragment of EBV het DNA (7, 21), we investigated whether the BALF4 gene product (gB, or glycoprotein gp110) was expressed. When incorporated into the standard virus at high levels, gB expands the range of EBV target cells beyond just B lymphocytes (44) . By RT-PCR, BALF4 mRNA was detected in the two SVK5 clones; representative results with SVK5 clone 4G2 are shown in Fig. 5B . On the possibility that methylation and/or chromatin modification of the integrated concatemer might diminish expression, cells were treated with DNA methyltransferase inhibitors and histone deacetylases. Although mRNA was readily detected in the untreated cells, maximum expression was obtained with a combination of 5-aza-2Ј-deoxycytidine and sodium butyrate (Fig. 5B) . Cytoplasmic gB was evident in cell subsets from both SVK5 clones when probed with the biotinylated gB-specific CL55 MAb (76) that was detected by streptavidin (Fig. 5C ).
DISCUSSION
The outcome of infection achieved here with a mixed inoculum of standard EBV and defective het DNA confirms in an epithelial cell culture system an observation made previously in clinical biopsy samples of EBV-associated lymphomas: the persistence of rearranged, deleted EBV het DNA in the absence of the standard parental viral genome (13, 51) . Successful propagation of het DNA in the absence of the standard EBV genome in long-term culture offers the singular prospect for a more thorough characterization of a hitherto-elusive component of EBV infection and makes this cell line useful in modeling the process by which het DNA impacts EBV latency, persistence, and disease. Initial results described here suggest at least a potential for het DNA to alter the natural history of EBV infection, both at the acute establishment phase and in reactivation events occurring over the lifelong EBV carrier state.
Critical to successful establishment of EBV infection in all cell types are factors that promote EBV genome amplification immediately upon viral entry and the subsequent expression of EBNA1 for episomal maintenance. Due to its constitutive expression of the immediate-early protein Zta, het DNA has the potential to affect both. In epithelial cells, where early lytic gene expression has recently been shown to be required for the initial increase in episomal copy number (57), het DNA might increase infection efficiency by rapid episomal amplification of the coinfecting standard virus genome. However, we observed that SVK infection with het DNA had a similar viral genome copy number as the het DNA-negative infected cells at early times postinfection (1 dpi) (Fig. 3B) . Instead, it appears that het DNA-transcribed Zta may interfere with the establishment and persistent phases of infection by downregulating latency promoters critical for EBNA1 expression. Indeed, in latently infected BL cells, the spontaneous generation of het DNA was associated with EBV reactivation and elimination of EBV episomes (64) .
Although the suppressive effect of Zta on latency promoter reporter constructs as well as EBNA1 expression was evident in gene transfer studies where Zta was driven by heterologous promoters (5, 28, 61, 66) , a like result was not accomplished with sodium butyrate-, TPA-, or IgG cross-linking-induced replication of latent virus (66, 75, 78) . Indeed, the Wp/Cpcontrolled latency III pattern of EBV gene expression has been demonstrated to subsist in vivo in lytically infected cells where Zta is expressed (73, 74) , suggesting that the overexpression of BZLF1-encoded Zta from strong heterologous promoters may be responsible for the discrepancy. These inconsistencies are what makes the approximately 7-fold downregulation of EBNA1 by het DNA in two acutely infected epithelial cell cultures (SVK and CCL-20.2) studied here particularly striking ( Fig. 1 and 2) . Observed under the more physiologically relevant conditions of acute infection, our result was similar to that achieved by the forced expression of BZLF1. The apparent potency of WZhet-encoded Zta in the suppression of EBNA1 may be a consequence of the rearrangement of regulatory elements upstream and downstream of WZhet fragment (53), a gene dosage effect due to the concatemeric structure of het DNA (Fig. 4) or possibly a functional difference in het DNAencoded Zta itself (8) .
Also notable was the varied EBNA1 promoter usage by the standard P3HR-1 genome in the absence (Wp/Cp) or presence (Qp) of het DNA (Fig. 2C) . Although in epithelial cell culture, very little Wp/Cp-initiated EBNA1 transcription is typically observed (31, 57) , previous studies have utilized EBV strains that (unlike P3HR-1) did not contain the EBNA2 gene deletion. In EBV-positive biopsy samples of both oral hairy leukoplakia (74) and Burkitt's lymphomas (26, 27) where EBNA2 gene-deleted viral genomes were present, however, cells displayed an atypical Wp-restricted form of latency in which Wp rather than Qp was active. The apparent lack of activity of Wp/Cp in coinfected SVK5 cells may reflect the ability of WZhet-encoded Zta protein to downregulate these promoters under conditions comparable to natural infections. If a similar effect also holds true in B lymphocytes, where Wp/Cp activity is crucial to the successful establishment of the carrier state, het DNA may significantly alter the outcome of infection.
The chance integration of het DNA into SVK5 cells provided further evidence for the transmission of het DNA in a concatemeric form. Definition at the nucleotide level of abnormally juxtaposed sequences constituting the link between individual het DNA units in SVK5 cells prompted an examination of cell-free virion DNA for the identical rearrangement that would corroborate the packaging and transmission of infectious het DNA as a concatemer. In both the integrated het DNA molecule and virion DNA, a truncated Nhet fragment was abnormally approximated to the sequence GGGGCATG GGG, previously shown to define both ends of the linear EBV genome (65, 81) . Those 11 nucleotides are reiterated within the terminal repeats in the motif GGGGTGGGGCATGGGG, which occurs at the exact locus of interconversion between linear and circular EBV DNA as well as at junctions of other recombinogenic events in EBV (65) . Indeed, the human genome contains similar GC-rich recombinogenic elements as variable-number tandem repeat (VNTR) sequences (33) , the switch region of gamma immunoglobulin genes (59) , and chromosomal telomere sequences (72) , supporting the notion of a functional role for such motifs. Whether this rearrangement, or the recently delineated points of recombination between EBV DNA fragments comprising a het DNA monomer (18) , confer novel biological properties such as seen with WZhet remains to be shown.
While concatemerization of defective het DNA monomers has yielded yet another point of recombination involved in the generation of het DNA, it also raises interesting possibilities with regard to gene dosage effects. A case in point is our detection of BALF4-encoded gB in het DNA-positive SVK5 cells (Fig. 5C ). It has been reported that the amount of gB incorporated into virions markedly varies among EBV strains and that augmented incorporation dramatically improves the efficiency of infection of B cells while expanding the target cell range to cell types previously refractory to EBV. Cotransfection of a BALF4 expression vector into BZLF1-induced cells bearing virus low in gB produced infectious progeny that not only were 100-fold more efficient at infecting lymphocytes but also displayed an expanded infectious spectrum to include T cells and epithelial cells (44) . The concurrent expression of both BZLF1-encoded Zta and gB in het DNA-positive SVK5 cells (Fig. 5) raises the possibility that het DNA may have a like effect in the chronic carrier state, disrupting EBV latency while enhancing virulence of progeny virus. If true, this adds a dimension to EBV reactivation that may distinguish intermittent shedding typical of the healthy lifelong carrier of virus from the disruption of latency occurring as a precursor to disease.
